Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 01 - 07 symbols : Sny save search
Preliminary Safety and Efficacy of PBCAR0191, an Allogeneic ‘Off-the-Shelf’ CD19-Directed CAR-T for Patients with Relapsed/Refractory (R/R) CD19+ B-ALL
Published: 2022-01-07 (Crawled : 19:00) - precisionbiosciences.com
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
| Email alert
Add to watchlist
DTIL | $9.86 -8.02% 140K
|
Health Technology
| Email alert
Add to watchlist
pbcar0191 car-t
Allogeneic CAR-T PBCAR0191 with Intensified Lymphodepletion is Highly Active in Subjects with Relapsed/Refractory B-Cell Malignancies
Published: 2022-01-07 (Crawled : 19:00) - precisionbiosciences.com
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
| Email alert
Add to watchlist
DTIL | $9.86 -8.02% 140K
|
Health Technology
| Email alert
Add to watchlist
pbcar0191 car-t cel t-cell
Global Depression Drugs Market to Surpass US$ 15,379.0 Million by 2028, Says Coherent Market Insights
Published: 2022-01-07 (Crawled : 19:00) - prnewswire.com
PFE A | $25.91 2.05% 22M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $138.24 800
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.19 0.23% 740K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
| Email alert
Add to watchlist
LLY | $727.48 -2.48% 2M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 510
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.585 0.8% 1.1M
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.41 0.07% 2.9M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.6 1.28% 5.6M
|
Health Technology
| Email alert
Add to watchlist
drug depression market
Hematopoietic Stem Cells Transplantation Market to Record USD 1.99 Bn Growth | AllCells Corp., bluebird bio Inc., and FUJIFILM Holdings Corp. emerge as dominant players | Technavio
Published: 2022-01-07 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
ema cel stem cell growth merge
Sanofi Jumps on Early 2022 AI Train with Exscentia Deal
Published: 2022-01-07 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
deal train
Movers & Shakers, Jan. 7
Published: 2022-01-07 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.37%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
OPT | $3.4 3.4K
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: 0.06%
GEVO | $0.625 3.77% 11M
|
Process Industries
|
| O: 1.89%
H: 0.0%
C: 0.0%
EXEL | $22.28 -0.93% 960K
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
RCEL | $8.67 -2.26% 160K
|
Health Technology
|
| O: 2.51%
H: 0.0%
C: 0.0%
Icosavax Provides Corporate Update and Anticipated Milestones for 2022
Published: 2022-01-07 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
ICVX | $15.31 -0.65% 9.3M
|
|
| O: 0.1%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
NVAX | $3.875 -0.39% 1.6M
|
Health Technology
|
| O: -1.88%
H: 0.0%
C: 0.0%
milestone
Regeneron and Ultragenyx Collaborate to Commercialize Evkeeza® (evinacumab) Outside the United States
Published: 2022-01-07 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
RARE F | $41.575 -4.16% 370K
|
Health Technology
|
| O: -6.46%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
REGN | $893.67 -0.04% 230K
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
evkeeza commercialization collaboration
Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines
Published: 2022-01-07 (Crawled : 09:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
research collaboration
2021’s Top Biopharma Mergers and Acquisitions
Published: 2022-01-07 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
biopharma acquisition acquisitions merge
Hemophilia Therapeutics Market to Record USD 4.47 Bn Growth | Baxter International Inc., Bayer AG, Biogen Inc., and CHIESI Farmaceutici SpA emerge as dominant players | Technavio
Published: 2022-01-07 (Crawled : 03:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
BAX | $39.47 -0.45% 1.3M
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
BIIB | $192.68 1.13% 590K
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
therapeutics growth merge
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.